Clinical Trial Participation

INSYS Therapeutics is recognized for its advances surrounding a progressive line of innovative drugs and novel drug delivery systems that improve the quality of patients' lives.

Through our clinical team, we aim to develop cutting-edge therapies that set new standards in supportive care and cancer treatment. Our team is dedicated to exploring interventions, examining methods and measuring ways to improve the comfort and quality of patients' lives. Research participation is vital to our success.

INSYS Therapeutics regularly reviews requests for program information and consideration from potential clinical trial research sites and investigators. To be considered, site and investigator information should be submitted to INSYS via email at clinicaltrials@insysrx.com.

hello
Drug Candidate Disease State Status
SYNDROS®
(dronabinol) oral solution
label expansion
(i) Anorexia in cancer patients

(ii) Agitation in Alzheimer’s disease
Cannabidiol (i) Childhood absence epilepsy

(ii) Infantile spasm

(iii) Prader-Willi Syndrome
Buprenorphine
sublingual spray
Moderate-to-severe acute pain
Naloxone
nasal spray
Opioid overdose
Epinephrine
nasal spray
Anaphylaxis reaction
Buprenorphine / Naloxone sublingual spray Opioid dependence
Rizatriptan
nasal spray
Migraine  
SUBSYS®
(fentanyl sublingual spray)
label expansion
(i) Post-operative pain

(ii) Pre-procedural pain

CANNABINOIDS

SPRAYS

Participate